Table 2. Relationship between clinicopathological characteristics of CRC patients and the Wnt inhibitory factor-1 (WIF-1) methylation status in the cancerous tissue.
Clinicopathological features | Number (n = 50) |
WIF-1 methylation status in the cancerous tissue | ||
---|---|---|---|---|
Methylated n = 28 |
Unmethylated n = 22 |
p-value* | ||
Age, mean ± SD, years | 60.4 ± 10.6 | 58.3 ± 12.6 | 0.535** | |
Gender | 0.166 | |||
Female/Male | 24/26 | 16/12 | 8/14 | |
Tumor size, cm | 0.264 | |||
≤ 5 | 23 | 15 | 8 | |
> 5 | 27 | 13 | 14 | |
Grade | 0.107*** | |||
I | 8 | 5 | 3 | |
II | 34 | 16 | 18 | |
III | 8 | 7 | 1 | |
Tumor location | 0.009 | |||
Left-sided | 27 | 20 | 7 | |
Right-sided | 23 | 8 | 15 | |
Stage | 0.999 | |||
I–II | 17 | 10 | 7 | |
III–IV | 33 | 18 | 15 | |
Histological type | 0.479 | |||
Mucinous | 10 | 7 | 3 | |
Non-mucinous | 40 | 21 | 19 | |
Lymph node metastasis | 0.153 | |||
Positive | 25 | 11 | 14 | |
Negative | 25 | 17 | 8 |
*determined by Fisher’s exact test; **determined by Student’s t-test; ***determined by chi-square test.